Gabie Ong, MD
Colon & Rectal Surgery · Surprise, AZNPI 1225470479
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,000 of the $4,772 with a category attached, or 62.9%. Intuitive Surgical accounts for 65.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $3,438 and has fallen 83.3% since, to $574 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in AZ, where the typical reported total is $5,787.
Across 55 payments — averaging $86.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Medtronic$747
- Johnson & Johnson$281
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$172
- AbbVie$106
- Biosense Webster, Inc.$103
- plus $219 from 8 others
What the payments were for
- Food & beverage$1,77237%
- Education$3,00063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $3,145 |
| Medtronic | 14 | $747 |
| Johnson & Johnson(2 entities) | 7 | $281 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $172 |
| AbbVie | 6 | $106 |
| Biosense Webster, Inc. | 1 | $103 |
| Baxter Healthcare | 2 | $96 |
| Conmed Corporation | 1 | $20 |
| Davol Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Merck | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- INTERSTIM$496
- NA$103
How this compares
$4,772 in reported general payments places this provider in the 45th percentile of 50 colon & rectal surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 26 | $116 |
| Tramadol Hcl | 11 | $32 |
| Levofloxacin | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Surprise
- Sushil PandeySurprise$125K
- Deborah KellerScottsdale$195K
- Eugene KimPhoenix$189K
- Hekmat HakimanChandler$57K
- Ashley CasanoPhoenix$48K
- Debora Fox-McclaryPhoenix$41K
- Michael BuckmireMesa$36K
- Nasrin GhalyaiePhoenix$22K
- Clarence ClarkChandler$19K
- Lynn CalcoteScottsdale$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.